Chartwell Molecular Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?
CHARTWELL MOLECULAR has sixteen approved drugs.
Drugs and US Patents for Chartwell Molecular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecular | IRBESARTAN | irbesartan | TABLET;ORAL | 077205-003 | Nov 14, 2012 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Molecular | CARVEDILOL | carvedilol | TABLET;ORAL | 077474-003 | Sep 5, 2007 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Molecular | IRBESARTAN | irbesartan | TABLET;ORAL | 077205-002 | Nov 14, 2012 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Molecular | RAMIPRIL | ramipril | CAPSULE;ORAL | 078745-004 | Jun 18, 2008 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Molecular | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077044-002 | Nov 5, 2004 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Molecular | CARVEDILOL | carvedilol | TABLET;ORAL | 077474-002 | Sep 5, 2007 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.